Erratum: Expression of Concern: Enterococcus durans TN-3 Induces Regulatory T Cells and Suppresses the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis (PLoS ONE (2016) 11:7 (e0159705) DOI: 10.1371/journal.pone.0159705);Enterococcus durans TN-3 induces regulatory T cells and suppresses the development of dextran sulfate sodium (DSS)-induced experimental colitis

PLoS ONE

Volumn 11, Issue 7, 2016, Pages

  Kanda, Toshihiro ^a   Nishida, Atsushi ^a   Ohno, Masashi ^a   Imaeda, Hirotsugu ^a   Shimada, Takashi ^b   Inatomi, Osamu ^a   Bamba, Shigeki ^a   Sugimoto, Mitsushige ^a   Andoh, Akira ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Central Research Laboratories   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CYTOKINE; DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; TN 3; UNCLASSIFIED DRUG; BUTYRIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DISEASE ACTIVITY; ENTEROCOCCUS DURANS; EXPERIMENTAL COLITIS; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE FLORA; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; CHEMISTRY; COLITIS; DISEASE MODEL; DRUG EFFECTS; ENTEROCOCCUS; FECES; HUMAN; IMMUNOLOGY; METABOLISM;

ANIMALS; BUTYRATES; COLITIS; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; ENTEROCOCCUS; FECES; HUMANS; MICE; MICE, INBRED BALB C; PROBIOTICS; T-LYMPHOCYTES, REGULATORY;

EID: 84979620552     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0279800     Document Type: Erratum

References (43)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448(7152):427-34. PMID: 17653185
2. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010; 28:573-621. doi: 10.1146/annurev-immunol-030409-101225 PMID: 20192811
3. Sheehan D, Moran C, Shanahan F. The microbiota in inflammatory bowel disease. J Gastroenterol. 2015; 50(5):495-507. doi: 10.1007/s00535-015-1064-1 PMID: 25808229
4. Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol. 2014; 49(5):785-98. doi: 10.1007/s00535-014-0953-z PMID: 24652102
5. Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. Journal of gastroenterology. 2008; 43(1):1-17. doi: 10.1007/s00535-007-2111-3 PMID: 18297430
6. Mayer L. Evolving paradigms in the pathogenesis of IBD. Journal of gastroenterology. 2010; 45(1):9-16. doi: 10.1007/s00535-009-0138-3 PMID: 19960355
7. Sands BE. Inflammatory bowel disease: past, present, and future. Journal of gastroenterology. 2007; 42(1):16-25. PMID: 17322989
8. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11(8):506-14. doi: 10.1038/nrgastro.2014.66 PMID: 24912386
9. Klein G, Pack A, Bonaparte C, Reuter G. Taxonomy and physiology of probiotic lactic acid bacteria. International journal of food microbiology. 1998; 41(2):103-25. PMID: 9704860
10. Nami Y, Abdullah N, Haghshenas B, Radiah D, Rosli R, Khosroushahi AY. Probiotic assessment of Enterococcus durans 6HL and Lactococcus lactis 2HL isolated from vaginal microflora. J Med Microbiol. 2014; 63(Pt 8):1044-51. doi: 10.1099/jmm.0.074161-0 PMID: 24913559
11. Avram-Hananel L, Stock J, Parlesak A, Bode C, Schwartz B. E durans strain M4-5 isolated from human colonic flora attenuates intestinal inflammation. Dis Colon Rectum. 2010; 53(12):1676-86. doi: 10.1007/DCR.0b013e3181f4b148 PMID: 21178864
12. Kondoh M, Hayashi A, Okamori M, Motonaga C, Enomoto T, Cheng L, et al. Effects of Enterococcus sp. isolated from deep seawater on inhibition of allergic responses in mice. Br J Nutr. 2009; 102(1):3-7. doi: 10.1017/S0007114508158998 PMID: 19079946
13. Kawada M, Arihiro A, Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol. 2007; 13(42):5581-93. PMID: 17948932
14. Mizoguchi A. Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci. 2012; 105:263-320. doi: 10.1016/B978-0-12-394596-9.00009-3 PMID: 22137435
15. Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Current protocols in immunology / edited by Coligan John E [et al]. 2014; 104:Unit 15.25.
16. Clapper ML, Cooper HS, Chang WC. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta pharmacologica Sinica. 2007; 28(9):1450-9. PMID: 17723178
17. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990; 98(3):694-702. PMID: 1688816
18. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Laboratory investigation; a journal of technical methods and pathology. 1993; 69(2):238-49. PMID: 8350599
19. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE Jr., Balish E, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. The Journal of clinical investigation. 1996; 98(4):945-53. PMID: 8770866
20. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003; 52(1):65-70. PMID: 12477762
21. Nishida A, Nagahama K, Imaeda H, Ogawa A, Lau CW, Kobayashi T, et al. Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cells. J Exp Med. 2012; 209(13):2383-94. doi: 10.1084/jem.20112631 PMID: 23209314
22. Nishida A, Lau CW, Zhang M, Andoh A, Shi HN, Mizoguchi E, et al. The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice. Gastroenterology. 2012; 142(4):865-74 e2. doi: 10.1053/j.gastro.2011.12.036 PMID: 22202458
23. Torii T, Kanemitsu K, Wada T, Itoh S, Kinugawa K, Hagiwara A. Measurement of short-chain fatty acids in human faeces using high-performance liquid chromatography: specimen stability. Annals of clinical biochemistry. 2010; 47(Pt 5):447-52. doi: 10.1258/acb.2010.010047 PMID: 20595408
24. Andoh A, Imaeda H, Aomatsu T, Inatomi O, Bamba S, Sasaki M, et al. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol. 2011; 46(4):479-86. doi: 10.1007/s00535-010-0368-4 PMID: 21253779
25. Nagashima K, Hisada T, Sato M, Mochizuki J. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol. 2003; 69(2):1251-62. PMID: 12571054
26. Dean-Ross D, Mills AL. Bacterial Community Structure and Function along a Heavy Metal Gradient. Applied and environmental microbiology. 1989; 55(8):2002-9. PMID: 16347991
27. Hill TC, Walsh KA, Harris JA, Moffett BF. Using ecological diversity measures with bacterial communities. FEMS microbiology ecology. 2003; 43(1):1-11. doi: 10.1111/j.1574-6941.2003.tb01040.x PMID: 19719691
28. Zeng H, Chi H. Metabolic control of regulatory T cell development and function. Trends in immunology. 2015; 36(1):3-12. doi: 10.1016/j.it.2014.08.003 PMID: 25248463
29. Andoh A. Physiological Role of Gut Microbiota for Maintaining Human Health. Digestion. 2016; 93(3):176-81. doi: 10.1159/000444066 PMID: 26859303
30. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013; 500(7461):232-6. doi: 10.1038/nature12331 PMID: 23842501
31. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011; 331(6015):337-41. doi: 10.1126/science.1198469 PMID: 21205640
32. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013; 504(7480):451-5. doi: 10.1038/nature12726 PMID: 24226773
33. Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 2004; 53(11):1617-23. PMID: 15479682
34. Tursi A, Brandimarte G, Papa A, Giglio A, Elisei W, Giorgetti GM, et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2010; 105(10):2218-27. doi: 10.1038/ajg.2010.218 PMID: 20517305
35. Sood A, Midha V, Makharia GK, Ahuja V, Singal D, Goswami P, et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol. 2009; 7(11):1202-9, 9 e1. doi: 10.1016/j.cgh.2009.07.016 PMID: 19631292
36. Raz I, Gollop N, Polak-Charcon S, Schwartz B. Isolation and characterisation of new putative probiotic bacteria from human colonic flora. Br J Nutr. 2007; 97(4):725-34. PMID: 17349085
37. Maynard CL, Harrington LE, Janowski KM, Oliver JR, Zindl CL, Rudensky AY, et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol. 2007; 8(9):931-41. PMID: 17694059
38. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011; 474(7351):298-306. doi: 10.1038/nature10208 PMID: 21677746
39. Kindlund B, Sjoling A, Yakkala C, Adamsson J, Janzon A, Hansson LE, et al. CD4 regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-beta. Gastric Cancer. 2016.
40. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol. 2004; 172(9):5213-21. PMID: 15100259
41. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504(7480):446-50. doi: 10.1038/nature12721 PMID: 24226770
42. Inan MS, Rasoulpour RJ, Yin L, Hubbard AK, Rosenberg DW, Giardina C. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology. 2000; 118(4):724-34. PMID: 10734024
43. Yin L, Laevsky G, Giardina C. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem. 2001; 276(48):44641-6. PMID: 11572859